All In MedTech

Device Trial Radar · NCT04985799

Comparing KIM to TVT Exact Sling

A Randomized Controlled Trial Comparing Retropubic KIM Sling to TVT Exact Midurethral Sling

Last checked: Nov 20, 2026Latest source record: Aug 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 147 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

147

Actual

Start

Aug 11, 2021

Primary completion

May 31, 2023

Study completion Jun 28, 2024

Sponsor

Lead sponsor
University of North Carolina, Chapel HillAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 2, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To assess to the non-inferiority of the retropubic Neomedic Knotless Incontinence Mesh (KIM) sling compared to the Gynecare Tension-free Vaginal Tape (TVT) Exact sling. Participants: Women 21 years or older with a diagnosis of stress urinary incontinence (SUI) or mixed urinary incontinence (MUI) with objective evidence of SUI planning surgery for stress urinary incontinence. Procedures (methods): Patients will be randomized to receive either the Gynecare TVT Exact sling or the retropubic Neomedic KIM sling. Patients will be followed for 1 year postoperatively.

Conditions

  • Stress Urinary Incontinence

Interventions

  • Gynecare TVT Exact Continence SystemDevice

    Participants will have placement of Gynecare TVT Exact sling.

  • Neomedic KIM (Knotless Incontinence Mesh)Device

    Participants will have placement of retropubic Neomedic KIM (Knotless Incontinence Mesh) sling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Success at 6 Weeks After SurgeryTime frame: 6 weeks after surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • UNC Hospitals Hillsborough Campus

    Hillsborough, North Carolina

  • Rex Hospital

    Raleigh, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.